Beneo: Prebiotic health claim rejections have put prospects “on hold”

By Shane Starling

- Last updated on GMT

Related tags Board of directors

The second part of this exclusive interview sees Beneo executive board member, Yves Servotte, explaining the cooling but not crushing effect of EU prebiotic health claim rejections on its inulin-chicory business.

“Prospects are on hold because people are a little bit hesitating about what to do and that’s fair,” ​he said. “But on the other hand there are other claims linked to the chicory products like fibre and there you know that fibre enrichment of products is really high in demand and that is where we are very effective.”

Servotte said the EU regulatory system was influencing more than just Europe and that areas like medical foods would grow in importance, but functional foods remained the company’s main focus.

“Our battle in the first instance is functional foods.”

Watch the first part of this interview here.

Related news

Show more

Related products

show more

New digestive wellness solution with clinical evidence

New digestive wellness solution with clinical evidence

Content provided by Symrise AG | 31-May-2024 | Product Brochure

16% of adults across the globe are suffering from constipation¹. Functional gastrointestinal disorders are a worldwide issue, impacting the life of 15,2%...

HRB probiotics in the HMO era

HRB probiotics in the HMO era

Content provided by Morinaga Milk Industry Co., Ltd. | 29-Apr-2024 | White Paper

Discover the science behind human-residential bifidobacteria (HRB) probiotics and their superior benefits for infants.

Related suppliers

Follow us

Products

View more

Webinars